catalpol has been researched along with Cancer of Colon in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Qiao, PF; Yao, L; Zeng, ZL | 1 |
| Fu, X; Liu, Z; Mao, M; Wu, Y; Yang, A; Zhu, P | 1 |
| Dai, W; Fei, B; Zhao, S | 1 |
1 trial(s) available for catalpol and Cancer of Colon
| Article | Year |
|---|---|
Efficacy, Safety, and Cost of Therapy of the Traditional Chinese Medicine, Catalpol, in Patients Following Surgical Resection for Locally Advanced Colon Cancer.
Topics: Colonic Neoplasms; Female; Humans; Iridoid Glucosides; Male; Medicine, Chinese Traditional; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Analysis; Treatment Outcome | 2018 |
2 other study(ies) available for catalpol and Cancer of Colon
| Article | Year |
|---|---|
Catalpol‑mediated microRNA‑34a suppresses autophagy and malignancy by regulating SIRT1 in colorectal cancer.
Topics: Aged; Animals; Apoptosis; Autophagy; Azoxymethane; Carcinogens; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Colorectal Neoplasms; Disease Models, Animal; Drugs, Chinese Herbal; Female; Gene Expression Regulation, Neoplastic; Humans; Iridoid Glucosides; Male; MicroRNAs; Middle Aged; Rats; Rats, Wistar; Rehmannia; Sirtuin 1; Up-Regulation | 2020 |
Catalpol suppressed proliferation, growth and invasion of CT26 colon cancer by inhibiting inflammation and tumor angiogenesis.
Topics: Animals; Aorta; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Humans; Inflammation; Iridoid Glucosides; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Neovascularization, Pathologic; Rats, Sprague-Dawley; Vasoconstriction | 2017 |